HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minilaparotomy and ovarian diathermy drilling for clomiphene resistant poly cystic ovarian disease.

AbstractBACKGROUND:
This study was carried out to determine the effectiveness and safety of minilaparotomy and ovarian drilling for sub fertile women with clomiphene resistant polycystic ovarian syndrome.
METHODS:
During a 2 year period (August 2000 to August 2002) 16 patients with polycystic ovarian disease were managed by minilaparotomy and ovarian drilling by diathermy. All the patients underwent full infertility workup and then treated with cyclical clomiphene citrate for 6 months.
RESULTS:
Six patients (37.5%) presented in age group 15-25 years. Eight patients (50.0%) were in age group 26-35 years. Only 2 (12.5%) patients presented in age group 36-44 years. Eleven (68.75%) patients had primary infertility. Five (31.25%) patients presented with secondary infertility. After treatment and 6 months follow up, ovulation occurred in 14 (87.5%) patients. Eleven (68.75%) women conceived pregnancy.
CONCLUSION:
Ovarian drilling is a powerful tool in the treatment of polycystic ovarian disease.
AuthorsAziz-un-Nisa Abbasi, Anwar Sultana, Raeesa Izhar, Shamshad Begum, Sadia Razaq
JournalJournal of Ayub Medical College, Abbottabad : JAMC (J Ayub Med Coll Abbottabad) 2003 Oct-Dec Vol. 15 Issue 4 Pg. 26-8 ISSN: 1025-9589 [Print] Pakistan
PMID15067828 (Publication Type: Journal Article)
Chemical References
  • Fertility Agents, Female
  • Clomiphene
Topics
  • Adolescent
  • Adult
  • Clomiphene (therapeutic use)
  • Electrocoagulation
  • Female
  • Fertility Agents, Female (therapeutic use)
  • Humans
  • Laparotomy
  • Polycystic Ovary Syndrome (surgery)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: